カテーテルおよび能動型埋め込み機器CDMOの世界市場

カテーテルおよび能動型埋め込み機器CDMOの世界市場は2030年までに188億米ドルに達する見込み

2024年に104億米ドルと推定されるカテーテルおよび能動型埋め込み機器CDMOの世界市場は、2024～2030年の分析期間にCAGR 10.5％で成長し、2030年には188億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるカテーテルは、CAGR 12.0％を記録し、分析期間終了時には78億米ドルに達すると予測されます。能動的植込み型機器セグメントの成長率は、分析期間中CAGR 9.7％と推定されます。

米国市場は28億米ドル、中国はCAGR14.5％で成長予測

米国のカテーテルおよび能動型埋め込み機器CDMO市場は、2024年に28億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに39億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは14.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.4%と9.3%と予測されています。欧州では、ドイツがCAGR約8.3％で成長すると予測されています。

世界の「カテーテルおよび能動型埋め込み機器CDMO」市場- 主要動向と促進要因のまとめ

カテーテルと能動インプラントにおけるCDMOサービスの需要が急増しているのはなぜか？

カテーテルと能動的埋め込みデバイスの市場は、複雑な患者の要求と急速に進化する医療技術の融合に後押しされ、大幅な上昇を見せています。この動向の中心にあるのは、心臓血管、神経血管、泌尿器、電気生理学の各用途で高度に専門化されたソリューションを提供するCDMO（開発製造受託機関）への依存の高まりです。医療機器OEM（相手先ブランド製造）が規制のハードルの高さと市場投入までの時間短縮の必要性に直面する中、CDMOは重要な戦略的パートナーとして台頭してきました。これらの専門企業は、規制遵守、精密工学、臨床グレードの製造における深い専門知識をもたらし、OEMが中核となる研究開発と商品化に集中できるようにしています。カテーテル開発では、原材料の選択から押出成形、最終的な滅菌や包装に至るまで、CDMOに管理させるケースが増えています。心調律管理装置、神経刺激装置、輸液ポンプなど、能動的な埋め込み器具の複雑化に伴い、マイクロエレクトロニクス、ソフトウェア統合、生体適合材料など、多領域の知識が要求されるが、これらすべてにハイエンドのCDMOが対応できる体制を整えています。

技術革新は製品開発パイプラインをどのように変容させるのか？

最先端の技術統合は、カテーテルや能動的埋め込み器具のCDMOの状況を根本的に変えています。極薄ポリマー、親水性コーティング、生体吸収性複合材料の使用など、材料科学における革新は、より安全で快適、かつ機能的なカテーテルの開発を可能にしています。同様に、能動的埋め込み器具の分野では、小型化と電力効率が次世代デバイスを推進する指針となっています。CDMOは、ワイヤレス・テレメトリー、充電式バッテリー、ソフトウェア制御の機能性を埋め込み型機器に取り入れる最前線にいます。さらに、複雑なカテーテル先端形状や植込み型機器のハウジングのプロトタイピングに3Dプリンティングの採用が進んでいます。IoT（モノのインターネット）と医療技術の融合もまた、リアルタイムでのデータ伝送が可能なスマートカテーテルや、治療パラメーターの自己モニタリングと調整が可能な埋め込み型デバイスなど、期待を再定義しています。強固な電子機器統合とソフトウェア検証能力を持つCDMOは、このイノベーション主導のエコシステムにおいて不可欠なパートナーとなっています。このような高精度で規制上の制約があるデバイスの製造規模を拡大するCDMOの能力は、市場加速の鍵となります。

どのような市場圧力がCDMOの関与戦略を形成しているのか？

競争の激しいヘルスケア環境、製品ライフサイクルの短縮、コスト圧力の高まりにより、OEMがCDMOとどのように関わっていくかが変化しています。アウトソーシングはもはやコスト効率だけにとどまらず、競争上の優位性を獲得するための戦略的な動きとなっています。CDMOは現在、初期設計やプロトタイピング、規制文書作成、臨床試験サポート、商業規模の生産に至るまで、統合されたエンドツーエンドのサービスを提供することが期待されています。さらに、FDA、MDR（EU）、NMPA（中国）などの機関による規制の枠組みが強化されているため、CDMOは製品のライフサイクル全体にわたって世界なコンプライアンスとトレーサビリティを確保しなければならないです。このような規制の複雑化により、OEMは確立された品質システム（ISO 13485認証など）、社内試験所、デジタルトレーサビリティプラットフォームを持つCDMOを求めるようになっています。CDMOの業界内でも統合が進んでおり、大手企業がニッチなテクノロジー企業を買収して、カテーテルや埋め込み型医療機器の分野での能力を拡大しています。この動向は、バンドルサービスの提供、開発期間の短縮、技術移転の合理化を可能にし、次世代医療機器の商業化を目指すOEMにとって重要な要素となっています。

カテーテルおよび能動型埋め込み機器CDMO市場の成長はいくつかの要因によって牽引されています。

カテーテルおよび能動型埋め込み機器CDMO市場の成長は、デバイスの複雑性、エンドユーザーのニーズ、医療機器業界における戦略的シフトに根ざしたいくつかの要因によって牽引されています。第一に、心血管疾患、神経疾患、糖尿病などの慢性疾患の有病率の上昇により、診断用および治療用の低侵襲デバイスの需要が増加しており、カテーテルや埋め込み型デバイスの開発ニーズが拡大しています。第二に、病院と臨床医は、設計の緻密さと精度を要求する小型化された多機能機器をますます好むようになっています。第三に、OEMは臨床革新と市場拡大に集中するため、製造や薬事申請などの非中核業務をCDMOに移管しています。さらに、医療機器市場では、患者に合わせたカテーテルのサイジングやプログラム可能なインプラントなど、パーソナライゼーションに向けた動きが加速しており、迅速なプロトタイピングや小ロット生産の専門知識を持つCDMOへの依存度が高まっています。ヘルスケア投資における地理的なシフト、特にアジア太平洋地域では政府が現地製造にインセンティブを与えており、地域CDMOの拡大にも拍車をかけています。最後に、医療技術新興企業に対するベンチャーキャピタルの資金調達の増加は、開発初期段階からのアウトソーシングを促進し、バリューチェーン全体でCDMOに持続的な成長機会を生み出しています。

セグメント

サービスカテゴリー（カテーテル、能動植込み型デバイス、神経調節デバイス、心不全デバイス、泌尿器植込み型デバイス）、エンドユーザー（医療機器OEM企業エンドユーザー、学術・研究機関エンドユーザー、政府機関エンドユーザー）

調査対象企業の例（計 34社）

• Abbott Laboratories
• Alvimedica
• Biomerics
• Biotronik
• Boston Scientific
• Catalent
• Cirtec Medical
• Cochlear Limited
• ConvaTec Group
• Freudenberg Medical
• Heraeus Group
• Integer Holdings
• LeMaitre Vascular
• Medtronic
• MicroPort
• OrbusNeich
• Recipharm
• Smith & Nephew
• Teleflex
• Vetter Pharma

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Catheters and Active Implantable CDMO Market to Reach US$18.8 Billion by 2030

The global market for Catheters and Active Implantable CDMO estimated at US$10.4 Billion in the year 2024, is expected to reach US$18.8 Billion by 2030, growing at a CAGR of 10.5% over the analysis period 2024-2030. Catheters, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$7.8 Billion by the end of the analysis period. Growth in the Active Implantable Devices segment is estimated at 9.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 14.5% CAGR

The Catheters and Active Implantable CDMO market in the U.S. is estimated at US$2.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 14.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 9.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global "Catheters and Active Implantable CDMO" Market - Key Trends & Drivers Summarized

Why Is There a Surge in Demand for CDMO Services in Catheters and Active Implantables?

The market for catheters and active implantable devices has seen a significant uptick, propelled by a fusion of complex patient demands and rapidly evolving medical technologies. At the heart of this trend lies the growing reliance on Contract Development and Manufacturing Organizations (CDMOs) to deliver highly specialized solutions across cardiovascular, neurovascular, urology, and electrophysiology applications. As medical device OEMs (Original Equipment Manufacturers) face mounting regulatory hurdles and the need for faster time-to-market, CDMOs have emerged as vital strategic partners. These specialized firms bring in-depth expertise in regulatory compliance, precision engineering, and clinical-grade manufacturing, enabling OEMs to focus on core R&D and commercialization. In catheter development, CDMOs are increasingly being tasked with managing everything from raw material selection and extrusion to final sterilization and packaging. The growing complexity of active implantables-such as cardiac rhythm management devices, neurostimulators, and infusion pumps-requires multidomain knowledge in microelectronics, software integration, and biocompatible materials, all of which high-end CDMOs are well-equipped to handle.

How Are Technological Innovations Transforming Product Development Pipelines?

Cutting-edge technological integration is radically reshaping the CDMO landscape for catheters and active implantables. Innovations in material science-such as the use of ultra-thin polymers, hydrophilic coatings, and bioresorbable composites-are enabling the development of catheters that are safer, more comfortable, and more functional. Similarly, in the active implantables domain, miniaturization and power efficiency are guiding principles driving next-gen devices. CDMOs are at the forefront of incorporating wireless telemetry, rechargeable batteries, and software-controlled functionalities in implantable devices. Additionally, 3D printing is being increasingly adopted for prototyping complex catheter tip geometries and housings for implantables. The convergence of IoT (Internet of Things) and MedTech is also redefining expectations, with smart catheters capable of real-time data transmission and implantables that can self-monitor and adjust therapy parameters. CDMOs with robust electronics integration and software validation capabilities are becoming indispensable partners in this innovation-driven ecosystem. Their ability to scale manufacturing of such high-precision, regulatory-bound devices is a key enabler of market acceleration.

What Market Pressures Are Shaping CDMO Engagement Strategies?

A highly competitive healthcare environment, shrinking product lifecycles, and increasing cost pressures are reshaping how OEMs engage with CDMOs. Outsourcing is no longer limited to cost-efficiency-it has become a strategic move to gain competitive advantage. CDMOs are now expected to offer integrated end-to-end services that span early design and prototyping, regulatory documentation, clinical trial support, and commercial-scale production. Moreover, with tightening regulatory frameworks by bodies such as the FDA, MDR (EU), and NMPA (China), CDMOs must ensure global compliance and traceability across the product life cycle. This regulatory complexity is pushing OEMs to seek CDMOs with established quality systems (such as ISO 13485 certification), in-house testing labs, and digital traceability platforms. Consolidation is also being witnessed within the CDMO space itself, with larger players acquiring niche technology firms to broaden capabilities across catheter and implantable verticals. This trend enables bundled service offerings, faster development timelines, and streamlined tech transfers-all critical factors for OEMs racing to commercialize next-gen medical devices.

The Growth In The Catheters And Active Implantable CDMO Market Is Driven By Several Factors……..

The growth in the catheters and active implantable CDMO market is driven by several factors rooted in device complexity, end-user needs, and strategic shifts within the MedTech industry. First, the rising prevalence of chronic conditions such as cardiovascular disease, neurological disorders, and diabetes is increasing demand for both diagnostic and therapeutic minimally invasive devices, expanding the need for catheter and implantable development. Second, hospitals and clinicians are increasingly favoring miniaturized, multifunctional devices that demand high levels of design intricacy and precision-capabilities typically concentrated within specialized CDMOs. Third, OEMs are offloading non-core operations such as manufacturing and regulatory submissions to CDMOs in order to focus on clinical innovation and market expansion. Furthermore, the medical device market’s push towards personalization-such as patient-specific catheter sizing or programmable implants-is increasing reliance on CDMOs with rapid prototyping and short-run manufacturing expertise. Geographic shifts in healthcare investments-particularly in Asia-Pacific, where governments are incentivizing local manufacturing-are also fueling regional CDMO expansions. Lastly, increased venture capital funding for MedTech startups is driving outsourcing from early development stages, creating sustained growth opportunities for CDMOs across the value chain.

SCOPE OF STUDY:

The report analyzes the Catheters and Active Implantable CDMO market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Category (Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices, Urology Implantable Devices); End-Use (Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use, Government Agencies End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Alvimedica
• Biomerics
• Biotronik
• Boston Scientific
• Catalent
• Cirtec Medical
• Cochlear Limited
• ConvaTec Group
• Freudenberg Medical
• Heraeus Group
• Integer Holdings
• LeMaitre Vascular
• Medtronic
• MicroPort
• OrbusNeich
• Recipharm
• Smith & Nephew
• Teleflex
• Vetter Pharma

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Catheters and Active Implantable CDMO - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Burden of Chronic Diseases Drives Demand for Specialized Catheter and Implant Production
  • Surge in Minimally Invasive Procedures Expands Outsourcing Opportunities for CDMOs
  • Technological Advancements in Catheter Design Accelerate Product Development Pipelines
  • Increasing Complexity of Implantable Devices Strengthens Business Case for Specialized CDMO Services
  • Regulatory Stringency Encourages OEMs to Leverage CDMO Regulatory Expertise
  • Demand for Drug-Eluting and Smart Catheters Drives Need for Advanced Manufacturing Capabilities
  • Rise in Aging Population Generates Demand for Cardiac and Neuromodulation Implants
  • Expansion of Wearable and Connected Medical Devices Boosts Demand for Micro-Precision CDMOs
  • CDMO Involvement in Early-Stage Product Design Drives Co-Innovation Opportunities
  • Shift Toward Value-Based Healthcare Expands Opportunities for Cost-Efficient CDMO Solutions
  • Development of Bioresorbable Implants Spurs Innovation in Materials and Coatings
  • Stringent IP and Quality Standards Highlight Importance of Full-Service CDMO Offerings
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Catheters and Active Implantable CDMO Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Catheters and Active Implantable CDMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Catheters and Active Implantable CDMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Active Implantable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Active Implantable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Active Implantable Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Neuromodulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Neuromodulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Neuromodulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Heart Failure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Heart Failure Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Heart Failure Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Urology Implantable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Urology Implantable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Urology Implantable Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Medical Device OEM Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Medical Device OEM Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Medical Device OEM Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Government Agencies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Government Agencies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Government Agencies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 47: China Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: China 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 50: China Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: China Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: China 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Catheters and Active Implantable CDMO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Catheters and Active Implantable CDMO by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Europe 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 62: France Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: France 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 65: France Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: France Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: France 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 71: Germany Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Germany Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Germany 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 77: Italy Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Italy Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Italy 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 80: UK Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 83: UK Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: UK Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: UK 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 86: Spain Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Spain Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Spain 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 89: Spain Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Spain Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Spain 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 92: Russia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Russia Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Russia 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 95: Russia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Russia Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Russia 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Rest of Europe Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Rest of Europe 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Rest of Europe Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Rest of Europe 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Catheters and Active Implantable CDMO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Catheters and Active Implantable CDMO by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Asia-Pacific Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Asia-Pacific 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Asia-Pacific Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Asia-Pacific 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 113: Australia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Australia Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Australia 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 116: Australia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Australia Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: Australia 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 119: India Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: India Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: India 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 122: India Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: India Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: India 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 125: South Korea Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: South Korea Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: South Korea 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 128: South Korea Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: South Korea Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: South Korea 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Asia-Pacific Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Asia-Pacific Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 137: Latin America Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 138: Latin America Historic Review for Catheters and Active Implantable CDMO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Latin America 16-Year Perspective for Catheters and Active Implantable CDMO by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 140: Latin America Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Latin America Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Latin America 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 143: Latin America Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Latin America Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Latin America 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 146: Argentina Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Argentina Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Argentina 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 149: Argentina Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Argentina Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Argentina 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 152: Brazil Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Brazil Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Brazil 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 155: Brazil Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Brazil Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Brazil 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 158: Mexico Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Mexico Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Mexico 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 161: Mexico Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Mexico Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Mexico 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Rest of Latin America Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Rest of Latin America 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Rest of Latin America Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Rest of Latin America 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 170: Middle East Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 171: Middle East Historic Review for Catheters and Active Implantable CDMO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Middle East 16-Year Perspective for Catheters and Active Implantable CDMO by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 173: Middle East Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Middle East Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Middle East 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 176: Middle East Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Middle East Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Middle East 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 179: Iran Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Iran Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Iran 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 182: Iran Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Iran Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Iran 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 185: Israel Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Israel Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Israel 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 188: Israel Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Israel Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Israel 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Saudi Arabia Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Saudi Arabia 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Saudi Arabia Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Saudi Arabia 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 197: UAE Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: UAE Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: UAE 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 200: UAE Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: UAE Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: UAE 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Middle East Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Middle East 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Middle East Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Rest of Middle East 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Catheters and Active Implantable CDMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 209: Africa Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Africa Historic Review for Catheters and Active Implantable CDMO by Service Category - Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Africa 16-Year Perspective for Catheters and Active Implantable CDMO by Service Category - Percentage Breakdown of Value Sales for Catheters, Active Implantable Devices, Neuromodulation Devices, Heart Failure Devices and Urology Implantable Devices for the Years 2014, 2025 & 2030
  • TABLE 212: Africa Recent Past, Current & Future Analysis for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Africa Historic Review for Catheters and Active Implantable CDMO by End-Use - Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Africa 16-Year Perspective for Catheters and Active Implantable CDMO by End-Use - Percentage Breakdown of Value Sales for Medical Device OEM Companies End-Use, Academic & Research Institutes End-Use and Government Agencies End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION